
Mylin Ann Torres MD
Assistant Professor, Radiation Oncology, Emory University School of Medicine
Join to view full profile
1365 Clifton Rd NeAtlanta, GA 30322
Phone+1 404-778-3473
Fax+1 404-778-4139
Dr. Torres is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2004 - 2008
Alameda Health System-Highland HospitalInternship, Transitional Year, 2003 - 2004
Stanford University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2008 - 2028
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (All CQM's), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Lung Dose and Pneumonitis Risk Following Five-Fraction Breast Radiotherapy.Kristin A Ward, Matthew J Case, Matthew Thomas, Sheela Hanasoge, Mylin A Torres
Journal of Medical Imaging and Radiation Oncology. 2026-06-23 - 1 citationsSentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights.Ko Un Park, Raymond B Mailhot Vega, Samantha Shams, Jeffrey Hawley, Mark R Somerfield
JCO Oncology Practice. 2026-05-01 - 3 citationsNegative 18 F-FES PET/CT Despite Estrogen Receptor Positivity by Immunohistochemistry.Ismaheel O Lawal, Xiaoxian Li, Elizabeth A Sakach, Clara R Farley, Jane L Meisel
Clinical Nuclear Medicine. 2026-04-01
Press Mentions
ASCO Makes Major Changes to Early-Stage Breast Cancer GuidelineMay 20th, 2025
Missing Evidence: Drug-Radiotherapy Combinations in Breast CancerOctober 25th, 2022
Breast Cancer Genetics, Recurrence, and RT: Recent Research ContextNovember 13th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









